2018 Year end predictions

Discussion in 'Avanir Pharmaceuticals' started by anonymous, Apr 15, 2018 at 12:12 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Several depts downsized completely or moved under Otsuka once DOJ case finalizes.
    Onzetra gone.
    Sales forces stripped down to the minimum and then moved under Otsuka arm.
    Avanir as a commercialization company is over, beginning in 2019, R&D only.

    Wa’el, next time you get a CEO opportunity, hire someone to help you look the part. You present yourself as a slob.

    Aziz, enjoy the time you have, unfortunately this experience will haunt your resume and career like the rest of us.

    So most have about 6 months to get out before you are pushed. Get it together and go.
     

  2. anonymous

    anonymous Guest




    This would surprise absolutely no one. Dumpster fire of epic proportions.
     
  3. anonymous

    anonymous Guest

    Well, at least 20 people out of 100
    made their Nuedexta quota.
    lol
    And the goals went up ??
    Ah, maybe the goals are not being set right ?
     
  4. anonymous

    anonymous Guest

    Q1 goals were by far the easiest to attain and we are way behind. The next 3 Quarters worth are unattainable. All part of the plan to lay off more folks using performance as the reason so severance packages are limited.

    Get out.
     
  5. anonymous

    anonymous Guest

    Never seen a company implode so spectacularly. Well deserved.
     
  6. anonymous

    anonymous Guest

    PIPs flying everywhere
     
  7. anonymous

    anonymous Guest

    Can anybody be surprised by all this? My mgr won P-Club and is happy. So embarrassed for him. Wait till he interviews at other jobs and tries to explain how he won by coaching in the muddy off-label waters.
     
  8. anonymous

    anonymous Guest

    Are you an idiot? Do you think a manager is going to talk about how their reps hit their numbers by promoting off label? NO, it was because of their great leadership, and coaching etc.
     
  9. anonymous

    anonymous Guest

    Rudys got your IP
     
  10. anonymous

    anonymous Guest

    You idiot!! you don't get it! Everybody knows how a manager wins P-Club at Avnr, u idiot. Again, good luck trying to find another leadership position.
     
  11. anonymous

    anonymous Guest

    Any NAM that has a psych thats blowing out Nuedexta is using it off label , true fact, and no managers want to know about it or acknowledge it.
     
  12. anonymous

    anonymous Guest

    If only this placebo really worked.
     
  13. anonymous

    anonymous Guest

    What about 786? Blockbuster or Bomb?
     
  14. anonymous

    anonymous Guest

    Do you really wanna wait around 3 years to find out?
     
  15. anonymous

    anonymous Guest

    They are not expecting us to make goals. The commercial was trash.
     
  16. anonymous

    anonymous Guest

    Everyone, including PClub winners know that all high volume writers prescribe Nuedexta off label. The company encourages off label scripts, they just won't ever admit it for compliance purposes.
     
  17. anonymous

    anonymous Guest

     
  18. anonymous

    anonymous Guest

    why is our Onzetra insurance coverage so terrible, ?
    And why is Nuedexta insurance coverage
    actually worse than it’s was 2 years ago,?
    You would think coverage would be getting better, but it’s actually getting worse. Our managed care people must
    be about the worst in the industry.
     
  19. anonymous

    anonymous Guest

    Onzetra Has huge generic competition

    CNN is why Nuedexta coverage is much worse than ever
     
  20. anonymous

    anonymous Guest

    The fact that someone comes on here and states that “anyone with high NDX volume is selling off label” is an absolute joke. I don’t sell off label, never have. My Doctors don’t write off label, never have. Yes, certain people cheated their assed off back in the day but those days are over. They cleaned house and now most of those reps are at Neurocrine.